Q2 Earnings Estimate for Sage Therapeutics Issued By Wedbush
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at Wedbush raised their Q2 2025 earnings estimates for shares of Sage Therapeutics in a research note issued on Tuesday, April 29th. Wedbush analyst L. Chico now expects that the biopharmaceutical company will earn ($0.97) per share for the quarter, up from their prior estimate […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at Wedbush raised their Q2 2025 earnings estimates for shares of Sage Therapeutics in a research note issued on Tuesday, April 29th. Wedbush analyst L. Chico now expects that the biopharmaceutical company will earn ($0.97) per share for the quarter, up from their prior estimate […]
